Altogether, these data suggest that um-PEA reduces abnormal tau phosphorylation in the hippocampus of 3×Tg-AD mice at 6 and 12 months of age, and that such an effect may be partially mediated by the Gsκ-3β/Akt pathway. This evidence concerns the gene MAPT and Alzheimer disease.